Company Filing History:
Years Active: 2025
Title: Sydney A Barnes: Innovator in Therapeutic Antibodies
Introduction
Sydney A Barnes is a prominent inventor based in La Jolla, CA (US). She has made significant contributions to the field of therapeutic compositions, particularly in the development of binding polypeptides that target DLL3. Her innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Sydney A Barnes holds 1 patent for her invention titled "DLL3 single domain antibodies and therapeutic compositions thereof." This patent provides binding polypeptides that specifically bind to DLL3. It includes fusion proteins, such as multivalent and/or multispecific constructs and chimeric antigen receptors, that target DLL3. Additionally, the patent covers pharmaceutical compositions containing these polypeptides, nucleic acid molecules encoding them, and methods for their use in treating diseases, including cancer.
Career Highlights
Sydney A Barnes is associated with Inhibrx Biosciences, Inc., where she continues to advance her research and development efforts. Her work focuses on creating innovative therapeutic solutions that can address critical health challenges.
Collaborations
Some of her notable coworkers include Brendan P Eckelman and Michael D Kaplan, who collaborate with her in the pursuit of groundbreaking therapeutic advancements.
Conclusion
Sydney A Barnes is a trailblazer in the field of therapeutic antibodies, with her work on DLL3 binding polypeptides paving the way for new cancer treatments. Her contributions to science and medicine are invaluable and continue to inspire future innovations.